merck glp-1 agonist GLP-1s Five Unexpected New Uses for
Description
Why Switch Between GLP-1 Receptor Agonists
A baseline and follow-up eye exam ensures that ocular risk factors are balanced against systemic gains, the report states
The hope: Retatrutide may become an important future option if FDA review supports approval
Risks: Increased heart rate, potential worsening of heart failure with reduced ejection fraction, and rare complications like hypoglycemia or retinopathy
Diem, Ducluzeau, Scheen)
